Ken Schupp has over 30 years of experience in the pharmaceutical industry, with a focus on quality control and analytical chemistry. Ken currently holds the position of Executive Director of Quality Control at Heron Therapeutics, Inc., where they have been since July 2021. Prior to that, they served as the Senior Director of Quality Control at Heron Therapeutics, Inc. from December 2017 to July 2021. Before joining Heron Therapeutics, Inc., Ken held various roles at BioDelivery Sciences International, Biogen Idec, Purdue Pharmaceuticals L.P., Novo Nordisk Pharmaceuticals, and Alcami.
From 1986 to 1990, Ken Schupp attended PennWest California, though no degree or field of study was mentioned.
July, 2021 - present
December, 2017